{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:30:15Z","timestamp":1793190615546,"version":"4.5.0"},"reference-count":86,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T00:00:00Z","timestamp":1723680000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Medicina"],"abstract":"<jats:p>The development of percutaneous coronary intervention (PCI) has been one of the greatest advances in cardiology and has changed clinical practice for patients with coronary artery disease (CAD). Despite continuous improvements in operators\u2019 experience, techniques, and the development of new-generation devices, significant challenges remain in improving the efficacy of PCI, including calcification, bifurcation, multivascular disease, stent restenosis, and stent thrombosis, among others. The present review aims to provide an overview of the current status of knowledge of endovascular revascularization in CAD, including relevant trials, therapeutic strategies, and new technologies addressing particular scenarios that can impact the prognosis of this vulnerable population.<\/jats:p>","DOI":"10.3390\/medicina60081323","type":"journal-article","created":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T09:29:41Z","timestamp":1723714181000},"page":"1323","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Challenges and Advances in Interventional Cardiology for Coronary Artery Disease Management"],"prefix":"10.3390","volume":"60","author":[{"given":"Leslie Marisol","family":"Lugo-Gavidia","sequence":"first","affiliation":[{"name":"Mexican Academic Consortium for Clinical Data Acquisition SC, Sinaloa 80230, Mexico"},{"name":"Dobney Hypertension Centre, Medical School, University of Western Australia, Perth 6000, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Antonio","family":"Alcocer-Gamba","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad Aut\u00f3noma de Quer\u00e9taro, Santiago de Quer\u00e9taro 76180, Mexico"},{"name":"Instituto de Coraz\u00f3n de Quer\u00e9taro, Santiago de Quer\u00e9taro 76180, Mexico"},{"name":"Centro de Estudios Cl\u00ednicos de Quer\u00e9taro, Santiago de Quer\u00e9taro 76180, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Araceli","family":"Martinez-Cervantes","sequence":"additional","affiliation":[{"name":"Facultad de Medicina, Universidad Aut\u00f3noma de Quer\u00e9taro, Santiago de Quer\u00e9taro 76180, Mexico"},{"name":"Centro de Estudios Cl\u00ednicos de Quer\u00e9taro, Santiago de Quer\u00e9taro 76180, Mexico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,8,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global Burden of Cardiovascular Diseases and Risk Factors, 1990\u20132019: Update from the GBD 2019 Study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","unstructured":"Mariachiara Di Cesare, H.B., Gaziano, T., Hadeed, L., Kabudula, C., McGhie, D.V., Mwangi, J., Pervan, B., Perel, P., Pi\u00f1eiro, D., and Taylor, S. (2023). World Heart Report 2023: Confronting the World\u2019s Number One Killer, World Heart Federation."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-981-15-2517-9_3","article-title":"Revascularization for Coronary Artery Disease: Principle and Challenges","volume":"1177","author":"Gu","year":"2020","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_4","first-page":"559","article-title":"Interinstitutional clinical practice guidelines for the treatment of acute myocardial infarction","volume":"156","year":"2020","journal-title":"Gac. Med. Mex."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1093\/ehjacc\/zuad107","article-title":"2023 ESC Guidelines for the management of acute coronary syndromes: Developed by the task force on the management of acute coronary syndromes of the European Society of Cardiology (ESC)","volume":"13","author":"Byrne","year":"2024","journal-title":"Eur. Heart J. Acute Cardiovasc. Care"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.4244\/EIJ-D-21-00694","article-title":"How to set up regional STEMI networks: A \u201cStent\u2014Save a life!\u201d initiative","volume":"17","author":"Candiello","year":"2022","journal-title":"EuroIntervention"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"T87","DOI":"10.4244\/EIJV10STA14","article-title":"Stent for Life Initiative: Leading example in building STEMI systems of care in emerging countries","volume":"10","author":"Kaifoszova","year":"2014","journal-title":"EuroIntervention"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1002\/ccd.29896","article-title":"STEMI telemedicine for 100 million lives","volume":"98","author":"Mehta","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Writing Committee Members, Virani Salim, S., Newby, L.K., Arnold Suzanne, V., Bittner, V., Brewer LaPrincess, C., Demeter Susan, H., Dixon Dave, L., Fearon William, F., and Hess, B. (2023). 2023 AHA\/ACC\/ACCP\/ASPC\/NLA\/PCNA Guideline for the Management of Patients with Chronic Coronary Disease. J. Am. Coll. Cardiol., 82, 833\u2013955.","DOI":"10.1016\/j.jacc.2023.04.003"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s40292-021-00497-z","article-title":"Contemporary Management of Stable Coronary Artery Disease","volume":"29","author":"Bertolone","year":"2022","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/eurheartj\/ehz425","article-title":"2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes","volume":"41","author":"Knuuti","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4330\/wjc.v13.i8.237","article-title":"ISCHEMIA trial: How to apply the results to clinical practice","volume":"13","author":"Peteiro","year":"2021","journal-title":"World J. Cardiol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa1915922","article-title":"Initial Invasive or Conservative Strategy for Stable Coronary Disease","volume":"382","author":"Maron","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_14","first-page":"383","article-title":"Intravascular Ultrasound for the Assessment of Coronary Lesion Severity and Optimization of Percutaneous Coronary Interventions","volume":"4","author":"Park","year":"2015","journal-title":"Interv. Cardiol. Clin."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1056\/NEJMoa2216607","article-title":"Intravascular Imaging-Guided or Angiography-Guided Complex PCI","volume":"388","author":"Lee","year":"2023","journal-title":"N. Engl. J. Med."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"768","DOI":"10.4244\/EIJV6I6A130","article-title":"Assessment of the coronary calcification by optical coherence tomography","volume":"6","author":"Kume","year":"2011","journal-title":"EuroIntervention"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3904\/kjim.2012.27.1.1","article-title":"The role of optical coherence tomography in coronary intervention","volume":"27","author":"Terashima","year":"2012","journal-title":"Korean J. Intern. Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2324","DOI":"10.1056\/NEJMoa0806576","article-title":"Diagnostic performance of coronary angiography by 64-row CT","volume":"359","author":"Miller","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1161\/01.CIR.92.11.3183","article-title":"Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow","volume":"92","author":"Pijls","year":"1995","journal-title":"Circulation"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCULATIONAHA.109.850073","article-title":"Long-term clinical outcome after fractional flow reserve-guided treatment in patients with angiographically equivocal left main coronary artery stenosis","volume":"120","author":"Hamilos","year":"2009","journal-title":"Circulation"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1163\/156856203321478838","article-title":"Bioresorbable polymeric stents: Current status and future promise","volume":"14","author":"Eberhart","year":"2003","journal-title":"J. Biomater. Sci. Polym. Ed."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","article-title":"One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial","volume":"109","author":"Stone","year":"2004","journal-title":"Circulation"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"N. Engl. J. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1161\/CIRCULATIONAHA.106.675934","article-title":"Drug-eluting stent and coronary thrombosis: Biological mechanisms and clinical implications","volume":"115","author":"Steffel","year":"2007","journal-title":"Circulation"},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"The BASKET-LATE-Study (2006). Basel stent cost-effectiveness trial-late thrombotic events trial. Herz, 31, 259.","DOI":"10.1007\/s00059-006-2828-4"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.jcin.2012.12.125","article-title":"Final 5-year outcomes from the Endeavor zotarolimus-eluting stent clinical trial program: Comparison of safety and efficacy with first-generation drug-eluting and bare-metal stents","volume":"6","author":"Kandzari","year":"2013","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.jacc.2009.08.067","article-title":"A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial","volume":"55","author":"Leon","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.jcin.2010.08.021","article-title":"Long-term clinical outcomes with zotarolimus-eluting versus bare-metal coronary stents","volume":"3","author":"Mauri","year":"2010","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Zong, J., He, Q., Liu, Y., Qiu, M., Wu, J., and Hu, B. (2022). Advances in the development of biodegradable coronary stents: A translational perspective. Mater. Today Bio, 16.","DOI":"10.1016\/j.mtbio.2022.100368"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","article-title":"A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): An interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jacc.2023.05.003","article-title":"5-Year Outcomes After Bioresorbable Coronary Scaffolds Implanted With Improved Technique","volume":"82","author":"Stone","year":"2023","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1016\/j.jacc.2017.10.010","article-title":"3-Year Clinical Outcomes With Everolimus-Eluting Bioresorbable Coronary Scaffolds: The ABSORB III Trial","volume":"70","author":"Kereiakes","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/j.carrev.2020.04.006","article-title":"Sustained Safety and Performance of the Second-Generation Sirolimus-Eluting Absorbable Metal Scaffold: Pooled Outcomes of the BIOSOLVE-II and -III Trials at 3 Years","volume":"21","author":"Haude","year":"2020","journal-title":"Cardiovasc. Revasc Med."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e389","DOI":"10.4244\/EIJ-D-21-00651","article-title":"Magnesium-based resorbable scaffold vs permanent metallic sirolimus-eluting stent in patients with ST-segment elevation myocardial infarction: 3-year results of the MAGSTEMI randomised controlled trial","volume":"18","author":"Brugaletta","year":"2022","journal-title":"EuroIntervention"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_18_19","article-title":"\u201cThe Unpredictable ABSORB\u201d\u2014Very Late Stent Thrombosis of Bioresorbable Vascular Scaffold","volume":"20","author":"Pradhan","year":"2019","journal-title":"Heart Views"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/CIRCULATIONAHA.110.976829","article-title":"How to minimize stent thrombosis","volume":"124","author":"Kirtane","year":"2011","journal-title":"Circulation"},{"key":"ref_37","first-page":"93","article-title":"Prevention of stent thrombosis: Challenges and solutions","volume":"11","author":"Reejhsinghani","year":"2015","journal-title":"Vasc. Health Risk Manag."},{"key":"ref_38","first-page":"320","article-title":"Coronary Stent Thrombosis- Predictors and Prevention","volume":"117","author":"Ullrich","year":"2020","journal-title":"Dtsch. Arztebl. Int."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaccas.2021.01.023","article-title":"Management of Iatrogenic Coronary Artery Dissections: Failing to Prepare Is Preparing to Fail","volume":"3","author":"Fischman","year":"2021","journal-title":"JACC Case Rep."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2174\/1573403X10666140404105923","article-title":"Coronary stent fracture: A recently appreciated phenomenon with clinical relevance","volume":"10","author":"Chinikar","year":"2014","journal-title":"Curr. Cardiol. Rev."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jjcc.2018.03.001","article-title":"Dual antiplatelet therapy after coronary stent implantation: Individualizing the optimal duration","volume":"72","author":"Lugo","year":"2018","journal-title":"J. Cardiol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/ehjcvp\/pvz023","article-title":"Ticagrelor in patients with myocardial infarction: Is the treatment strategy crystal clear?","volume":"5","author":"Lugo","year":"2019","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/eurheartj\/ehx419","article-title":"2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS: The Task Force for dual antiplatelet therapy in coronary artery disease of the European Society of Cardiology (ESC) and of the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"39","author":"Valgimigli","year":"2018","journal-title":"Eur. Heart J."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.1056\/NEJMoa1908419","article-title":"Ticagrelor with or without Aspirin in High-Risk Patients after PCI","volume":"381","author":"Mehran","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1001\/jama.2020.7580","article-title":"Effect of Ticagrelor Monotherapy vs Ticagrelor with Aspirin on Major Bleeding and Cardiovascular Events in Patients with Acute Coronary Syndrome: The TICO Randomized Clinical Trial","volume":"323","author":"Kim","year":"2020","journal-title":"JAMA"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/S0140-6736(17)32155-4","article-title":"Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): A randomised, open-label, multicentre trial","volume":"390","author":"Sibbing","year":"2017","journal-title":"Lancet"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: Developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies With the special contribution of the European Association of Preventive Cardiology (EAPC)","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur. Heart J."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jcin.2010.10.013","article-title":"Global risk classification and clinical SYNTAX (synergy between percutaneous coronary intervention with TAXUS and cardiac surgery) score in patients undergoing percutaneous or surgical left main revascularization","volume":"4","author":"Capodanno","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jcin.2010.12.003","article-title":"Toward better stratification of patients with left main disease: Value of clinical and angiographic-derived risk scores","volume":"4","author":"Applegate","year":"2011","journal-title":"JACC Cardiovasc. Interv."},{"key":"ref_50","first-page":"100549","article-title":"Complete revascularization for patients with multivessel coronary artery disease and ST-segment elevation myocardial infarction after the COMPLETE trial: A meta-analysis of randomized controlled trials","volume":"29","author":"Bajraktari","year":"2020","journal-title":"Int. J. Cardiol. Heart Vasc."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1056\/NEJMoa1907775","article-title":"Complete Revascularization with Multivessel PCI for Myocardial Infarction","volume":"381","author":"Mehta","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e807","DOI":"10.4244\/EIJ-E-22-00018","article-title":"Definitions and Standardized Endpoints for Treatment of Coronary Bifurcations","volume":"19","author":"Lunardi","year":"2023","journal-title":"EuroIntervention"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.recesp.2014.05.017","article-title":"Do We Know How to Treat Bifurcation Coronary Lesions?","volume":"67","author":"Alfonso","year":"2014","journal-title":"Rev. Esp. Cardiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"V23","DOI":"10.4244\/EIJV11SVA5","article-title":"Definitions and classifications of bifurcation lesions and treatment","volume":"11","author":"Louvard","year":"2015","journal-title":"EuroIntervention"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/hrt.2002.007682","article-title":"Percutaneous coronary intervention for bifurcation coronary disease","volume":"90","author":"Louvard","year":"2004","journal-title":"Heart"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.4244\/EIJ-D-20-00169","article-title":"Percutaneous coronary intervention for bifurcation coronary lesions: The 15(th) consensus document from the European Bifurcation Club","volume":"16","author":"Burzotta","year":"2021","journal-title":"EuroIntervention"},{"key":"ref_57","first-page":"e45023","article-title":"Detailed Morphometric Analysis on Left Coronary Artery in the Population of North-East India","volume":"15","author":"Manpoong","year":"2023","journal-title":"Cureus"},{"key":"ref_58","first-page":"e18","article-title":"2021 ACC\/AHA\/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"145","author":"Lawton","year":"2022","journal-title":"Circulation"},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/eurheartj\/ehy394","article-title":"2018 ESC\/EACTS Guidelines on myocardial revascularization","volume":"40","author":"Neumann","year":"2019","journal-title":"Eur. Heart J."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e01","DOI":"10.15420\/ecr.2020.32","article-title":"The EXCEL Trial: The Interventionalists\u2019 Perspective","volume":"16","author":"Hunter","year":"2021","journal-title":"Eur. Cardiol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s12055-020-00965-6","article-title":"NOBLE trial-is it time to revise the guidelines?","volume":"36","author":"Narayan","year":"2020","journal-title":"Indian. J. Thorac. Cardiovasc. Surg."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"e008151","DOI":"10.1161\/JAHA.117.008151","article-title":"Management of Left Main Coronary Artery Disease","volume":"7","author":"Ramadan","year":"2018","journal-title":"J. Am. Heart Assoc."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1056\/NEJM198705283162204","article-title":"Compensatory enlargement of human atherosclerotic coronary arteries","volume":"316","author":"Glagov","year":"1987","journal-title":"N. Engl. J. Med."},{"key":"ref_64","first-page":"101259","article-title":"SCAI Expert Consensus Statement on the Management of Calcified Coronary Lesions","volume":"3","author":"Riley","year":"2024","journal-title":"J. Soc. Cardiovasc. Angiogr. Interv."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11886-021-01458-7","article-title":"Therapeutic Approach to Calcified Coronary Lesions: Disruptive Technologies","volume":"23","author":"Shlofmitz","year":"2021","journal-title":"Curr. Cardiol. Rep."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"154","DOI":"10.15420\/icr.2019.19.R1","article-title":"Contemporary Approach to Heavily Calcified Coronary Lesions","volume":"14","author":"Nardi","year":"2019","journal-title":"Interv. Cardiol."},{"key":"ref_67","doi-asserted-by":"crossref","unstructured":"Lugo-Gavidia, L.M., Nolde, J.M., Carnagarin, R., Burger, D., Chan, J., Robinson, S., Bosio, E., Matthews, V.B., and Schlaich, M.P. (2022). Association of Circulating Platelet Extracellular Vesicles and Pulse Wave Velocity with Cardiovascular Risk Estimation. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms231810524"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1016\/j.jacc.2009.10.061","article-title":"Prediction of cardiovascular events and all-cause mortality with arterial stiffness: A systematic review and meta-analysis","volume":"55","author":"Vlachopoulos","year":"2010","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1161\/01.RES.0000243583.39694.1f","article-title":"Homocysteine and cardiovascular disease: Is HDL the link?","volume":"99","author":"Barter","year":"2006","journal-title":"Circ. Res."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1111\/jch.14265","article-title":"Homocysteine predicts vascular target organ damage in hypertension and may serve as guidance for first-line antihypertensive therapy","volume":"23","author":"Carnagarin","year":"2021","journal-title":"J. Clin. Hypertens."},{"key":"ref_71","first-page":"135","article-title":"Novel biomarkers for cardiovascular risk prediction","volume":"14","author":"Wang","year":"2017","journal-title":"J. Geriatr. Cardiol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.thromres.2019.01.021","article-title":"High and low on-treatment platelet reactivity to P2Y(12) inhibitors in a contemporary cohort of acute coronary syndrome patients undergoing percutaneous coronary intervention","volume":"175","author":"Ferreiro","year":"2019","journal-title":"Thromb. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1161\/HYPERTENSIONAHA.121.16975","article-title":"Role of Microparticles in Cardiovascular Disease: Implications for Endothelial Dysfunction, Thrombosis, and Inflammation","volume":"77","author":"Burger","year":"2021","journal-title":"Hypertension"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1097\/HJH.0000000000003248","article-title":"Platelet-derived extracellular vesicles correlate with therapy-induced nocturnal blood pressure changes","volume":"40","author":"Burger","year":"2022","journal-title":"J. Hypertens."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Lugo-Gavidia, L.M., Burger, D., Nolde, J.M., Matthews, V.B., and Schlaich, M.P. (2022). Evaluation of Circulating Platelet Extracellular Vesicles and Hypertension Mediated Organ Damage. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232315150"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1111\/jch.14479","article-title":"Circulating platelet-derived extracellular vesicles correlate with night-time blood pressure and vascular organ damage and may represent an integrative biomarker of vascular health","volume":"24","author":"Carnagarin","year":"2022","journal-title":"J. Clin. Hypertens."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.thromres.2020.08.041","article-title":"Association of fractalkine with functional severity of heart failure and impact on clopidogrel efficacy in patients with ischemic heart disease","volume":"196","author":"Marcano","year":"2020","journal-title":"Thromb. Res."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1160\/TH16-11-0837","article-title":"Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events","volume":"117","author":"Christersson","year":"2017","journal-title":"Thromb. Haemost."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.ijcard.2003.10.029","article-title":"Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes","volume":"97","author":"Jy","year":"2004","journal-title":"Int. J. Cardiol."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0002-8703(03)00103-0","article-title":"High levels of circulating endothelial microparticles in patients with acute coronary syndromes","volume":"145","author":"Jy","year":"2003","journal-title":"Am. Heart J."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"6437","DOI":"10.1007\/s11033-013-2758-1","article-title":"Circulating microparticles in patients with coronary heart disease and its correlation with interleukin-6 and C-reactive protein","volume":"40","author":"Cui","year":"2013","journal-title":"Mol. Biol. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1093\/eurheartj\/ehq478","article-title":"Circulating CD31+\/Annexin V+ microparticles correlate with cardiovascular outcomes","volume":"32","author":"Sinning","year":"2011","journal-title":"Eur. Heart J."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S0140-6736(13)61170-8","article-title":"Platelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): A prospective multicentre registry study","volume":"382","author":"Stone","year":"2013","journal-title":"Lancet"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1056\/NEJMoa1907096","article-title":"A Genotype-Guided Strategy for Oral P2Y(12) Inhibitors in Primary PCI","volume":"381","author":"Claassens","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ccd.29305","article-title":"Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent","volume":"98","author":"Kerkmeijer","year":"2021","journal-title":"Catheter. Cardiovasc. Interv."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e200512","DOI":"10.1148\/ryct.2021200512","article-title":"Artificial Intelligence in Cardiovascular Imaging for Risk Stratification in Coronary Artery Disease","volume":"3","author":"Lin","year":"2021","journal-title":"Radiol. Cardiothorac. Imaging"}],"container-title":["Medicina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1323\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T15:37:14Z","timestamp":1760110634000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1648-9144\/60\/8\/1323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,15]]},"references-count":86,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2024,8]]}},"alternative-id":["medicina60081323"],"URL":"https:\/\/doi.org\/10.3390\/medicina60081323","relation":{},"ISSN":["1648-9144"],"issn-type":[{"value":"1648-9144","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,15]]}}}